Valens Secures Sales Licence for Greater Toronto Area Beverage Facility
KELOWNA, BC, Nov. 2, 2022 /PRNewswire/ - The Valens Company Inc. (TSX: VLNS) (NASDAQ: VLNS) (the "Company" or "Valens") (the "Company," "The Valens Company" or "Valens"), a leading manufacturer of cannabis products, announced it has received a sales licence amendment from Health Canada for its Pommies manufacturing facility located in the Greater Toronto Area (the "GTA Facility") to sell micro processed cannabis products directly to provincial distributors.
- KELOWNA, BC, Nov. 2, 2022 /PRNewswire/ - The Valens Company Inc. (TSX: VLNS) (NASDAQ: VLNS) (the "Company" or "Valens") (the "Company," "The Valens Company" or "Valens"), a leading manufacturer of cannabis products, announced it has received a sales licence amendment from Health Canada for its Pommies manufacturing facility located in the Greater Toronto Area (the "GTA Facility") to sell micro processed cannabis products directly to provincial distributors.
- Prior to this announcement, Valens leveraged its British Columbia sales licence to sell into the provincial distributors which created additional cost and complexity in our supply chain.
- "Since the opening of our facility in November 2021 we have already seen an increase in our beverage margins," said Tyler Robson, Chief Executive Officer of Valens.
- Nothing herein should be construed as either an offer to sell or a solicitation to buy or sell securities of The Valens Company.